Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$702M |
| 2 |
Applied Materials
AMAT
|
+$507M |
| 3 |
Keurig Dr Pepper
KDP
|
+$387M |
| 4 |
KeyCorp
KEY
|
+$383M |
| 5 |
Visa
V
|
+$349M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$948M |
| 2 |
Broadcom
AVGO
|
+$446M |
| 3 |
NXP Semiconductors
NXPI
|
+$434M |
| 4 |
Analog Devices
ADI
|
+$309M |
| 5 |
Lam Research
LRCX
|
+$269M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 6.16% |
| 2 | Technology | 4.5% |
| 3 | Industrials | 4.26% |
| 4 | Consumer Discretionary | 4.07% |
| 5 | Healthcare | 3.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
7901
PUT
Safe Bulkers
SB
$795M
| $151K | ﹤0.01% |
44,400
+4,000
| +10% | +$13.3K |
|
|
ATTU
7902
DELISTED
Attunity Ltd
ATTU
| $151K | ﹤0.01% |
+12,972
| New | +$130K |
|
7903
CALL
Invesco DB Oil Fund
DBO
$403M
| $150K | ﹤0.01% |
12,000
-5,100
| -30% | -$60.5K |
|
7904
CALL
Navient
NAVI
$789M
| $150K | ﹤0.01% |
+11,500
| New | +$157K |
|
|
FTSI
7905
PUT
DELISTED
FTS International, Inc. Common Stock
FTSI
| $150K | ﹤0.01% |
+525
| New | +$192K |
|
7906
Galectin Therapeutics
GALT
$196M
| $149K | ﹤0.01% |
23,399
-44,147
| -65% | -$215K |
|
7907
Rafael Holdings
RFL
$101M
| $149K | ﹤0.01% |
16,461
-37,164
| -69% | -$293K |
|
|
SIGM
7908
CALL
DELISTED
Sigma Designs Inc
SIGM
| $149K | ﹤0.01% |
24,500
+14,500
| +145% | +$90K |
|
7909
Sprott Physical Gold
PHYS
$14.6B
| $148K | ﹤0.01% |
+14,536
| New | +$154K |
|
7910
CALL
Sumitomo Mitsui Financial
SMFG
$164B
| $148K | ﹤0.01% |
+19,000
| New | +$158K |
|
|
TEF
7911
PUT
DELISTED
Telefonica
TEF
| $148K | ﹤0.01% |
21,534
-3,837
| -15% | -$29.2K |
|
7912
CALL
Magnachip Semiconductor
MX
$119M
| $147K | ﹤0.01% |
14,300
+4,000
| +39% | +$41.4K |
|
7913
CALL
E.W. Scripps
SSP
$257M
| $147K | ﹤0.01% |
+11,000
| New | +$137K |
|
|
CCEC
7914
PUT
Capital Clean Energy Carriers
CCEC
$1.34B
| $147K | ﹤0.01% |
6,843
+43
| +0.6% | +$940 |
|
|
VSI
7915
PUT
DELISTED
Vitamin Shoppe Inc.
VSI
| $147K | ﹤0.01% |
21,200
-23,500
| -53% | -$128K |
|
7916
NexGen Energy
NXE
$6.06B
| $146K | ﹤0.01% |
78,942
+40,042
| +103% | +$80.1K |
|
7917
Valhi
VHI
$380M
| $146K | ﹤0.01% |
2,573
-1,842
| -42% | -$148K |
|
|
HSTO
7918
PUT
DELISTED
Histogen Inc. Common Stock
HSTO
| $146K | ﹤0.01% |
170
+83
| +95% | +$68.9K |
|
|
SVA
7919
CALL
DELISTED
Sinovac Biotech, Ltd
SVA
| $146K | ﹤0.01% |
19,600
-8,900
| -31% | -$70K |
|
7920
CALL
Aurinia Pharmaceuticals
AUPH
$1.91B
| $145K | ﹤0.01% |
25,700
-900
| -3% | -$5.02K |
|
|
CLSD
7921
CALL
DELISTED
Clearside Biomedical
CLSD
| $145K | ﹤0.01% |
+907
| New | +$153K |
|
|
VLRS
7922
Controladora Vuela Compania de Aviacion
VLRS
$900M
| $145K | ﹤0.01% |
+28,622
| New | +$178K |
|
7923
PUT
Wipro
WIT
$19.6B
| $145K | ﹤0.01% |
+80,533
| New | +$147K |
|
7924
PUT
B2Gold
BTG
$5B
| $144K | ﹤0.01% |
56,000
+3,700
| +7% | +$10.1K |
|
|
VRN
7925
CALL
DELISTED
Veren
VRN
| $144K | ﹤0.01% |
+19,600
| New | +$154K |
|
Similar funds
Citadel Advisors's Q2 2018 Portfolio in Review
As of Q2 2018, Citadel Advisors held 9,765 positions worth $203B, up 11% from $184B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Citadel Advisors deployed $8.95B of net new capital in Q2 2018, opening 1,572 new positions and adding to 4,160 existing holdings. Its largest new stake was Equitable Holdings: 16,008,962 shares worth $330M.
By sector, the portfolio is most concentrated in Financials at 6.2% of assets, up from 4.9% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $948M trimmed.
- Citadel Advisors's largest Q2 2018 buy was Equitable Holdings: 16,008,962 shares worth $330M.
- Citadel Advisors added most to Citigroup in Q2 2018, an estimated $702M increase.
- Citadel Advisors's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $948M.
- Citadel Advisors fully exited Time Warner Inc in Q2 2018, selling an estimated $268M.
- Citadel Advisors's ten largest holdings make up 24% of its $203B portfolio in Q2 2018.
- Citadel Advisors opened 1,572 new positions and closed 1,012 in Q2 2018.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $203B.
Based on Citadel Advisors's 13F filing for Q2 2018, filed 10 Aug 2018.